CANNAFLAM+®

Therapeutic benefits

• CB2 receptor ligands have been shown to inhibit inflammation and edema formation , exhibit analgesic effects, and play a protective role in hepatic ischemia-reperfusion injury. In the gastrointestinal tract, CB2 receptor agonists have been shown to prevent experimental colitis by reducing inflammation.
• Cartilage regeneration/ Osteoporosis: Osteoporosis is defined as the loss of bone mass and bone tissue, resulting in weak bones. Research has demonstrated that the CB1 receptor regulates peak bone mass through effects of osteoclasts, bone resorption and age-related bone loss. This means that the administered CBD helps to strengthen the fracture callus; the cartilage which mends the fracture. CBD involves changes to the organic matrix of bones that affects the flexibility and toughness.
• Cartilage regeneration/ Osteoporosis: Osteoporosis is defined as the loss of bone mass and bone tissue, resulting in weak bones. Research has demonstrated that the CB1 receptor regulates peak bone mass through effects of osteoclasts, bone resorption and age-related bone loss. This means that the administered CBD helps to strengthen the fracture callus; the cartilage which mends the fracture. CBD involves changes to the organic matrix of bones that affects the flexibility and toughness.
• Irritable Bowel Syndrome(IBS): Endocannabinoid system plays a vital role in regulating gut homeostasis. Its ability to modulate inflammatory responses demonstrates its part in preserving gastrointestinal function. Alterations of the ECS may predispose patients to pathologic disorders like IBS and creates more requirements of cannabinoids in body. Supply of CBD and THC in proper dose balances ECS and thus helps in curing IBS.
• Psoriasis: Psoriasis is a chronic skin condition caused by keratinocyte proliferation and inflammation due to hyperactive immune system. Up-regulation of both CB1 and CB2 receptor by CBD and THC suppresses keratinocyte proliferation and inflammation.